Department of Pathology, Genentech;
Department of Pathology, Genentech.
J Vis Exp. 2022 Jul 6(185). doi: 10.3791/62651.
Multiplexing enables the assessment of several markers on the same tissue while providing spatial context. Spatial Omics technologies allow both protein and RNA multiplexing by leveraging photo-cleavable oligo-tagged antibodies and probes, respectively. Oligos are cleaved and quantified from specific regions across the tissue to elucidate the underlying biology. Here, the study demonstrates that automated custom antibody visualization protocols can be utilized to guide ROI selection in conjunction with spatial proteomics assays. This specific method did not show acceptable performance with spatial transcriptomics assays. The protocol describes the development of a 3-plex immunofluorescent (IF) assay for marker visualization on an automated platform, using tyramide signal amplification (TSA) to amplify the fluorescent signal from a given protein target and increase the antibody pool to choose from. The visualization protocol was automated using a thoroughly validated 3-plex assay to ensure quality and reproducibility. In addition, the exchange of DAPI for SYTO dyes was evaluated to allow imaging of TSA-based IF assays on the spatial profiling platform. Additionally, we tested the ability of selecting small ROIs using the spatial transcriptomics assay to allow the investigation of highly-specific areas of interest (e.g., areas enriched for a given cell type). ROIs of 50 µm and 300 µm diameter were collected, which corresponds to approximately 15 cells and 100 cells, respectively. Samples were made into libraries and sequenced to investigate the capability to detect signals from small ROIs and profile-specific regions of the tissue. We determined that spatial proteomics technologies highly benefit from automated, standardized protocols to guide ROI selection. While this automated visualization protocol was not compatible with spatial transcriptomics assays, we were able to test and confirm that specific cell populations can successfully be detected even in small ROIs with the standard manual visualization protocol.
多重检测使人们能够在同一组织上同时评估多个标志物,同时提供空间背景信息。空间组学技术通过分别利用光可裂解的寡标记抗体和探针,实现蛋白质和 RNA 的多重检测。寡核苷酸从组织的特定区域被切割并定量,以阐明潜在的生物学机制。在这里,该研究表明,自动化定制抗体可视化方案可用于与空间蛋白质组学检测相结合,指导 ROI 选择。这种特定的方法在空间转录组学检测中表现不佳。该方案描述了开发一种用于在自动化平台上对标记物进行可视化的 3 重免疫荧光(IF)检测,使用辣根过氧化物酶信号放大(TSA)来放大给定蛋白靶标上的荧光信号,并增加可供选择的抗体池。该可视化方案使用经过彻底验证的 3 重检测自动化,以确保质量和重现性。此外,还评估了用 SYTO 染料替代 DAPI,以允许在空间分析平台上对基于 TSA 的 IF 检测进行成像。此外,我们还测试了使用空间转录组学检测选择小 ROI 的能力,以允许研究特定的高关注区域(例如,富含特定细胞类型的区域)。收集了 50 µm 和 300 µm 直径的 ROI,分别对应于大约 15 个细胞和 100 个细胞。对样本进行文库制备和测序,以研究检测小 ROI 和组织特定区域信号的能力。我们发现,空间蛋白质组学技术非常受益于自动化、标准化的方案来指导 ROI 选择。虽然这种自动化可视化方案与空间转录组学检测不兼容,但我们能够进行测试并确认,即使使用标准的手动可视化方案,也可以在小 ROI 中成功检测到特定的细胞群体。